Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE
McDermott Laboratories Ltd t/a Gerard Laboratories
C09DA08
OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE
20mg/25 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists and diuretics
Authorised
2014-12-12
Page 1 of 10 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE 20 MG/12.5 MG FILM-COATED TABLETS OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE 20 MG/25 MG FILM-COATED TABLETS (olmesartan medoxomil and hydrochlorothiazide) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Olmesartan medoxomil/Hydrochlorothiazide is and what it is used for 2. What you need to know before you take Olmesartan medoxomil/Hydrochlorothiazide 3. How to take Olmesartan medoxomil/Hydrochlorothiazide 4. Possible side effects 5. How to store Olmesartan medoxomil/Hydrochlorothiazide 6. Contents of the pack and other information 1. WHAT OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE IS AND WHAT IT IS USED FOR Olmesartan medoxomil/Hydrochlorothiazide contains two active substances, olmesartan medoxomil and hydrochlorothiazide, that are used to treat high blood pressure (hypertension): Olmesartan medoxomil is one of a group of medicines called angiotensin II-receptor antagonists. It lowers blood pressure by relaxing the blood vessels. Hydrochlorothiazide is one of a group of medicines called thiazide diuretics (“water tablets”). It lowers blood pressure by helping the body to get rid of extra fluid by making your kidneys produce more uri Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Olmesartan medoxomil/Hydrochlorothiazide 20 mg/25 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Olmesartan medoxomil and hydrochlorothiazide Each film-coated tablet contains 20 mg of olmesartan medoxomil and 25 mg of hydrochlorothiazide For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Yellow, film coated, oblong, biconvex beveled edge tablet debossed with ‘M’ on one side of the tablet and ‘H5’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension. Olmesartan medoxomil/Hydrochlorothiazide fixed dose combinations are indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil alone. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ Olmesartan medoxomil/Hydrochlorothiazide is not for use as initial therapy, but in patients whose blood pressure is not adequately controlled by olmesartan medoxomil alone. Olmesartan medoxomil/Hydrochlorothiazide is administered once daily, with or without food. When clinically appropriate, direct change from monotherapy with 20 mg olmesartan medoxomil to the fixed combination may be considered, taking into account that the antihypertensive effect of olmesartan medoxomil is maximal by about 8 weeks after initiating therapy (see section 5.1). Dose titration of the individual components is recommended: 20 mg olmesartan medoxomil/25 mg hydrochlorothiazide may be administered in patients whose blood pressure is not adequately controlled by 20 mg olmesartan medoxomil/12.5 mg hydrochlorothiazide. _Elderly (age 65 years or over)_ In older patients the same dosage of the combination is recommended as for adults. _Renal impairment_ When Olmesartan Read the complete document